ZSF1 rat as animal model for HFpEF: Development of reduced diastolic function and skeletal muscle dysfunction

AIMS: The prevalence of heart failure with preserved ejection fraction (HFpEF) is still increasing, and so far, no pharmaceutical treatment has proven to be effective. A key obstacle for testing new pharmaceutical substances is the availability of suitable animal models for HFpEF, which realisticall...

Descripción completa

Detalles Bibliográficos
Autores principales: Schauer, Antje, Draskowski, Runa, Jannasch, Anett, Kirchhoff, Virginia, Goto, Keita, Männel, Anita, Barthel, Peggy, Augstein, Antje, Winzer, Ephraim, Tugtekin, Malte, Labeit, Siegfried, Linke, Axel, Adams, Volker
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524062/
https://www.ncbi.nlm.nih.gov/pubmed/32710530
http://dx.doi.org/10.1002/ehf2.12915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524062/
https://www.ncbi.nlm.nih.gov/pubmed/32710530
http://dx.doi.org/10.1002/ehf2.12915

Ejemplares similares